SCHEMBL377223

SCHEMBL377223

ICCOCCOCCI

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1573071 1.00 MEN1 (0.38) MEN1KMT2ATSHRMAPK1
SCHEMBL1527574 1.00 MEN1 (0.38) MEN1KMT2ATSHRMAPK1
SCHEMBL1572848 1.00 MEN1 (0.38) MEN1KMT2ATSHRMAPK1
SCHEMBL1573282 1.00 MEN1 (0.38) MEN1KMT2ATSHRMAPK1
SCHEMBL270262 0.95
SCHEMBL14811180 0.89 MEN1 (0.32) MEN1KMT2A
SCHEMBL11294538 0.84 TSHR (0.30) TSHR
SCHEMBL1534459 0.83 CA2 (0.37)
SCHEMBL5301936 0.83 ALDH1A1 (0.43) TSHR
SCHEMBL17537501 0.83 HSD17B10 (0.36) MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 485 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116845307-B Perfluoro side chain grafted anion exchange membrane and preparation method thereof 大连理工大学 2026-05-15 CN claimed
WO-2025090284-A1 ELECTROLYTE COMPRISING SOLVENT WITH NON-FLUORINE HALOGEN SUBSTITUTE AND BATTERIES COMPRISING SAME FACTORIAL INC. (US) 2025-05-01 WO claimed
CN-119570222-A Degradable composite film paper material and preparation method thereof 广东道科新材料科技有限公司 2025-03-07 CN claimed
CN-119465289-A Anion exchange membrane, preparation method and application thereof, and electrolysis device 氢和元泰(常州)新材料科技有限公司 2025-02-18 CN claimed
CN-119092664-A Preparation method of carbon-based composite anode material of sodium ion battery 盐城师范学院 2024-12-06 CN claimed
CN-117986651-A Anion exchange membrane based on high free volume main chain and preparation method thereof 大连理工大学 2024-05-07 CN claimed
CN-116845307-A Perfluoro side chain grafted anion exchange membrane and preparation method thereof 大连理工大学 2023-10-03 CN claimed
CN-116371478-A Anion exchange membrane, preparation method and application thereof 同济大学 2023-07-04 CN claimed
CN-113234439-B Bovine serum albumin self-assembly triphenylamine photosensitizer and preparation method and application thereof 安徽大学 2022-08-02 CN claimed
CN-113717164-B Red fluorescent probe and preparation and application thereof in cell imaging 安徽大学 2022-05-10 CN claimed
US-20150174250-A1 Composition And Method RECKITT & COLMAN (OVERSEAS) LIMITED (GB) 2015-06-25 US claimed
US-20110008427-A1 Microcapsules and Methods UNIVERSITY OF LEEDS (GB) 2011-01-13 US claimed
US-20090155370-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY REMOVING POTASSIUM ION FROM THE GASTROINTESTINAL TRACT OF A MAMMAL RELYPSA, INC. (US) 2009-06-18 US claimed
WO-2007038801-A2 MONOVALENT CATION-BINDING COMPOSITIONS COMPRISING CORE-SHELL PARTICLES HAVING CROSSLINKED POLY-VINYLIC SHELLS, AND METHODS OF USE THEREOF ILYPSA, INC. (US) 2007-04-05 WO claimed
US-4597903-A Process for the direct preparation of N,N-disubstituted derivatives for 4,13-diaza-18-crown-6 UNIVERSITY OF MARYLAND (US) 1986-07-01 US claimed
CN-116845307-B Perfluoro side chain grafted anion exchange membrane and preparation method thereof 大连理工大学 2026-05-15 CN disclosed
US-12624042-B2 Compound for targeted degradation of BTK and anti-tumour use thereof SHANGHAI MEIZER PHARMACEUTICALS CO., LTD. (CN) 2026-05-12 US disclosed
US-4597903-A Process for the direct preparation of N,N-disubstituted derivatives for 4,13-diaza-18-crown-6 UNIVERSITY OF MARYLAND (US) 1986-07-01 US disclosed
US-4564690-A URANYL ION CAPTURING AGENT MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1986-01-14 US disclosed
US-4348377-A RADIOPACITY BRACCO INDUSTRIA CHIMICA S.P.A. (IT) 1982-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090155370-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY REMOVING POTASSIUM ION FROM THE GASTROINTESTINAL TRACT OF A MAMMAL KCNN3, KCNH3, KCNH2 MEN1 360/4885KMT2A 1769/4885TSHR 2033/4885
US-12624042-B2 Compound for targeted degradation of BTK and anti-tumour use thereof BTK, BCR, SYK MEN1 4290/4885KMT2A 1069/4885TSHR 2143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.